MECLIZINE HCL
- Product NDC
- 61919-641
- Requested package NDC
- 61919-641-20
- 11-digit product format
- 619190641
- Labeler code
- 61919
- Product ID
- 61919-641_86313229-5407-cd4d-e053-2991aa0a78f3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- MECLIZINE HCL
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Labeler
- DIRECTRX
- Application
- part336
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2019-04-10
- Marketing end
- 0000-00-00
- Substance
- MECLIZINE HYDROCHLORIDE
- Active strength
- 25 mg/251
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-641-20 | 61919064120 | 20 TABLET, CHEWABLE in 1 BOTTLE (61919-641-20) | 2019-04-10 | 0000-00-00 | No | No | Current |